AbCellera Investor Presentation Deck
July 2022, 37 slides
  1. AbCellera
  2. Related Decks
  3. Investor Presentation Decks
corporate overview oss | AbCellera
disclaimer rie | AbCellera
limited technologies fragmented approaches can keep pace with antibody drug discovery years years bring better antibodies to patients faster we deliver lead candidates in less time and with a higher probability of success snare | AbCellera
to build the best capabilities in the world from target to engine faster solve the unsolvable highest quality unprecedented scale | AbCellera
we provide partners with the competitive edge they need | AbCellera
forward integration to accelerate drug development meal | AbCellera
partnering with the best drug developers of all sizes we forge partnerships with large cap pharmaceutical companies companies of all sizes and non profit and government organizations through flexible deal structures royalties milestones equity equity like option to invest bill | AbCellera
illustrative revenue profile for one successful partnered program participation in programs is strongly weighted towards downstream success sears serene | AbCellera
covid antibody program similar revenue structure to typical program realized on a compressed | AbCellera
focussed on key value drivers probability of success speed portfolio volume deal structures a all | AbCellera
large diversified portfolio in next gen antibody therapies portfolio of programs with downstream participation is diversified across the following therapeutic areas mana talent | AbCellera
our partners look to us to unlock new targets next gen modalities pass membrane targets high homology targets peptide targets | AbCellera
custom built data science allows scalable integration of cutting edge tech with computation cal | AbCellera
make every step count complex data integration driven by interlocking technologies optimizes each step with a compounding effect on the entire process source search decode analyze engineer deliver | AbCellera
source search decode analyze engineer | AbCellera
team is everything a | AbCellera
strong portfolio growth | AbCellera
molecules in the clinic authorized for emergency use lily | AbCellera
capital efficient growth as basis for ongoing investment | AbCellera
tech stack source optimized immunization | AbCellera
access the of natural antibodies natural immune systems contain a massively diverse that encodes nature answers for fighting disease this can be used to develop the drugs of the future but it been challenging to access the billions of unique antibodies single cell finding the cell that makes it powered by over million years of evolution see | AbCellera
control immunity to generate better diversity we generate and access a high quality universe of antibodies for any target proprietary immunization methods any source any tissue human antibodies from rodents we trigger immune responses from any species with the goal of generating the best antibodies with the most diversity | AbCellera
more human antibodies from humanized mice source fully human antibodies from rodents to bypass the need to humanize sequences identified from non humanized animals with flagship mice eliminate reduce generate diversity is our game integrated access to humanized mice under competitive terms sens | AbCellera
tech stack search high throughput single cell screening functional assays | AbCellera
deeply search any antibody response with single cell assays | AbCellera
search for any antibody property smee | AbCellera
tech stack decode single cell repertoire profiling a | AbCellera
amplify lead candidates with repertoire sequencing | AbCellera
amplify options from a single cell lead through repertoire sequence mapping i | AbCellera
tech stack analyze high throughput expression tot tal | AbCellera
see the big picture with meaningful data we | AbCellera
select the best of the best use developability information to help select your best leads validate hundreds of antibodies with high throughput expression and characterization capabilities | AbCellera
tech stack engineer protein engineering development engine | AbCellera
combine any two antibodies to create native a aes | AbCellera
improve development of with a clinically validated platform faster development with native like format diverse panels stable manufacturable proven platform reel | AbCellera
engineer fit for purpose lead antibody candidates a san tch as a | AbCellera
investor relations | AbCellera
See More
AbCellera
Investor Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Downstream
Royalty
Clinic
Antibody discovery
Recent decks by AbCellera
Investor Presentation
February 2024
Investor Conference
January 2024
Results
November 2023
Investor Presentation
November 2023
See all presentations by AbCellera (23 decks)
Related decks
OmniAb
SPAC
March 2022
Ginkgo
Results
August 2021
OmniAb
Investor Conference
November 2022
OmniAb
Investor Presentation
August 2023
OmniAb
Investor Presentation
May 2023
OmniAb
Investor Conference
November 2022
Ginkgo
Investor Conference
June 2021
Theravance Biopharma
Results
February 2023
Recent decks by AbCellera
See all presentations (23 decks)
Investor Presentation
February 2024
Investor Conference
January 2024
Results
November 2023
Investor Presentation
November 2023
OmniAb
SPAC
March 2022
Ginkgo
Results
August 2021
OmniAb
Investor Conference
November 2022
OmniAb
Investor Presentation
August 2023
OmniAb
Investor Presentation
May 2023
OmniAb
Investor Conference
November 2022
Ginkgo
Investor Conference
June 2021
Theravance Biopharma
Results
February 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io